🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniel Aletaha

Medical University of Vienna

ORCID: 0000-0003-2108-0030
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative”.

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Arthritis & Rheumatism(2010)10.1002/art.27584
N/A
1.4DataRank · unranked
9467 citations

Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. Felson, Clifton O. Bingham +32 more

The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist

Annals of the Rheumatic Diseases(2022)10.1136/annrheumdis-2021-221801
N/A
0.737DataRank · unranked
135 citations

Zehra Serap Arıcı, David Piskin, Sara Alehashemi, Daniel Aletaha, Karyl S. Barron +26 more

The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)

Arthritis & Rheumatology(2023)10.1002/art.42636
N/A
0.590DataRank · unranked
50 citations

Ashley V. Geerlinks, Marta Wilejto, Kate F. Kernan, Melissa Hines, Micol Romano +26 more

The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin‐1 Mediated Autoinflammatory Diseases: Cryopyrin‐Associated Periodic Syndromes, Tumour Necrosis Factor Receptor‐Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin‐1 Receptor Antagonist

Arthritis & Rheumatology(2022)10.1002/art.42139
N/A
0.561DataRank · unranked
41 citations

Zehra Serap Arıcı, David Piskin, Sara Alehashemi, Daniel Aletaha, Karyl S. Barron +26 more

Reexamining Remission Definitions in Rheumatoid Arthritis: Considering Disease Activity Score in 28 Joints, C‐Reactive Protein, and Patient Global Assessment

ACR Open Rheumatology(2021)10.1002/acr2.11345
N/A
0.330DataRank · unranked
8 citations

Diane Lacaille, Michael P. LaValley, Daniel Aletaha, David T. Felson

Response to: Correspondence on ‘Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment' by Ferreira et al

Annals of the Rheumatic Diseases(2022)10.1136/annrheumdis-2021-221941
N/A
0.165DataRank · unranked
2 citations

Diane Lacaille, Michael P. LaValley, Daniel Aletaha, David T. Felson

POS0980 WHICH ACR RESPONSE DEFINITION SHOULD BE USED FOR DISEASE ACTIVITY CLAIMS IN APPROVAL STUDIES OF RHEUMATOID ARTHRITIS? A SYSTEMATIC EVALUATION

Annals of the Rheumatic Diseases(2023)10.1136/annrheumdis-2023-eular.4146
N/A
0DataRank · unranked
1 citations

Andreas Kerschbaumer, Josef S Smolen, Daniel Aletaha, Victoria Konzett

Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment

Annals of the Rheumatic Diseases(2021)10.1136/annrheumdis-2021-221653
N/A
0DataRank · unranked
18 citations

Diane Lacaille, Michael P. LaValley, Daniel Aletaha, David T. Felson

Reexamining Remission Definitions in Rheumatoid Arthritis: Considering the Twenty‐Eight–Joint Disease Activity Score, C‐Reactive Protein Level, and Patient Global Assessment

Arthritis & Rheumatology(2021)10.1002/art.41959
N/A
0DataRank · unranked
9 citations

Diane Lacaille, Michael P. LaValley, Daniel Aletaha, David T. Felson

Reexamining Remission Definitions in Rheumatoid Arthritis: Considering the Twenty‐Eight–Joint Disease Activity Score, C‐Reactive Protein Level, and Patient Global Assessment

Arthritis Care & Research(2021)10.1002/acr.24772
N/A
0DataRank · unranked
3 citations

Diane Lacaille, Michael P. LaValley, Daniel Aletaha, David T. Felson

The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS

Arthritis & Rheumatology(2022)10.1002/art.42087
N/A
0DataRank · unranked
47 citations

Lovro Lamot, Micol Romano, Erkan Demirkaya, David Piskin, Sofia Torreggiani +27 more

The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)

Annals of the Rheumatic Diseases(2023)10.1136/ard-2023-224123
N/A
0DataRank · unranked
142 citations

Ashley V. Geerlinks, Marta Wilejto, Kate F. Kernan, Melissa Hines, Micol Romano +45 more